Ce Dou
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms
Papers in
-
- Bone Metabolism and Diseases 34
- Circular RNAs in diseases 6
- Rheumatology 23
- Osteoarthritis Treatment and Mechanisms 15
- Co-authors
- Shiwu Dong (50 shared papers)Zhen Cao (27 shared papers)Yueqi Chen (12 shared papers)Fei Luo (32 shared papers)Jianzhong Xu (24 shared papers)Fei Kang (24 shared papers)Wenhui Hu (1 shared paper)Ning Ding (15 shared papers)
- Journals
- Journal of Cellular Physiology (8 papers)Bone Research (3 papers)The FASEB Journal (3 papers)Cell Death and Disease (3 papers)Advanced Science (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Ce Dou
79 papers receiving 2.9k citations
Ce Dou's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 687
- Rheumatology 655
- Orthopedics and Sports Medicine 282
- Molecular Biology 1.7k
- Oncology 546
Countries citing papers authored by Ce Dou
This map shows the geographic impact of Ce Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ce Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ce Dou more than expected).
Fields of papers citing papers by Ce Dou
This network shows the impact of papers produced by Ce Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ce Dou. The network helps show where Ce Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Ce Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis Hit paper breakdown → | 2020 | 330 |
| 2 | 2016 | 158 | |
| 3 | 2017 | 128 | |
| 4 | 2016 | 109 | |
| 5 | 2017 | 92 | |
| 6 | 2014 | 78 | |
| 7 | 2014 | 78 | |
| 8 | 2014 | 77 | |
| 9 | 2019 | 76 | |
| 10 | 2019 | 75 | |
| 11 | 2021 | 73 | |
| 12 | 2021 | 69 | |
| 13 | 2014 | 64 | |
| 14 | 2018 | 64 | |
| 15 | 2018 | 62 | |
| 16 | 2015 | 56 | |
| 17 | 2020 | 54 | |
| 18 | 2016 | 49 | |
| 19 | 2018 | 48 | |
| 20 | 2018 | 47 |
About Ce Dou
Ce Dou is a scholar working on Molecular Biology, Rheumatology, Cancer Research, Oncology and Immunology, having authored 84 papers that have together received 2.9k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (34 papers), MicroRNA in disease regulation (15 papers), Osteoarthritis Treatment and Mechanisms (15 papers), Bone health and treatments (14 papers), Bone Tissue Engineering Materials (11 papers), Cancer-related molecular mechanisms research (10 papers), Bone health and osteoporosis research (6 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (687 citations), Rheumatology (655 citations), Orthopedics and Sports Medicine (282 citations), Molecular Biology (1.7k citations) and Oncology (546 citations). Ce Dou has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Shiwu Dong, Zhen Cao, Yueqi Chen, Fei Luo, Jianzhong Xu, Fei Kang, Wenhui Hu, Ning Ding, Jian‐Mei Li and Yun Bai. Their work appears in journals such as Journal of Cellular Physiology, Bone Research, The FASEB Journal, Cell Death and Disease and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.